Medxy AI

Evaluating the Impact of the Pennsylvania Rural Health Model on Cancer Surgery Outcomes in Rural Hospitals

By MedXY 09/09/2026

The Pennsylvania Rural Health Model’s implementation did not significantly change short-term cancer surgery outcomes among rural residents, suggesting that alternative approaches may be necessary to improve surgical oncology care in rural settings.

news OB/GYN & Women's Health

Pre-pregnancy Uterine Surgery Linked to Increased Risks of Preterm Birth and Stillbirth: Insights from a Large Population Study

By MedXY 09/09/2026

Uterine surgery before first pregnancy is associated with increased risks of preterm birth and stillbirth, with risk magnifying after repeated procedures, highlighting the need for careful surgical decision-making and enhanced antenatal monitoring.

Clinical Updates news OB/GYN & Women's Health Psychiatry

Psychostimulant Continuation and Postpartum Mental Health in Pregnant People With Attention-Deficit/Hyperactivity Disorder: A Clinical Evidence Review

By MedXY 09/09/2026

This review synthesizes current evidence on the impact of continuing psychostimulant treatment during pregnancy on postpartum mental health outcomes among people with ADHD, highlighting key findings and clinical implications from recent large-scale cohort research.

Clinical Updates Neurology news

Tenecteplase Efficacy in Distal Cerebral Artery Occlusions: Insights From the Secondary Analysis of the TASTE Randomized Clinical Trial

By MedXY 09/09/2026

Secondary analysis of the TASTE trial reveals tenecteplase confers superior functional outcomes versus alteplase in patients with distal middle cerebral artery occlusions, supporting its use in more peripheral ischemic stroke territories.

Diabetes & Endocrinology news

Disentangling Fear and Hypoglycemia Metrics in Type 1 Diabetes: Insights from a 12-Month Diabetes Technology Study

By MedXY 09/09/2026

This 12-month analysis in adults with type 1 diabetes using advanced diabetes technology reveals that fear and perceived hypoglycemia frequency do not straightforwardly relate to continuous glucose monitoring metrics, highlighting complex drivers beyond glycemic data.

Cardiology Neurology news

Ischaemic Stroke Risk in Atrial Flutter Versus Atrial Fibrillation: Insights from a Finnish Nationwide Registry Study

By MedXY 09/09/2026

This Finnish nationwide study demonstrates that patients with atrial flutter have a substantially lower risk of ischaemic stroke compared to those with atrial fibrillation, highlighting important differences in thromboembolic risk profiles between these arrhythmias.

Cardiology news Public Health

Compound Exposure to Extreme Heat and Landscape Fire Pollution Amplifies Cardiovascular Mortality Risks

By MedXY 09/09/2026

A multinational study reveals that combined exposure to heat waves and substantial landscape fire-sourced air pollution significantly increases cardiovascular mortality, particularly from heart failure, more than either hazard alone, underscoring the need for integrated public health interventions.

Cardiology Clinical Updates news

Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Insights from ACACIA-HCM and Complementary Trials

By MedXY 09/09/2026

Aficamten, a cardiac myosin inhibitor, demonstrated significant improvements in symptoms, diastolic function, and biomarkers in nonobstructive hypertrophic cardiomyopathy across multiple trials, including the pivotal ACACIA-HCM study.

Hematology-Oncology news

Evaluating Cusatuzumab Combined with Venetoclax ± Azacitidine in Unfit Newly Diagnosed AML: Insights from the Phase Ib ELEVATE Trial

By MedXY 09/09/2026

The phase Ib ELEVATE study demonstrates that cusatuzumab combined with venetoclax and azacitidine offers a promising tolerable and effective frontline therapy for patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy.

Hematology-Oncology news

Csnk1a1 E98 Mutations: Metabolic and Signaling Rewiring in del(5q) Myelodysplastic Neoplasms

By MedXY 09/09/2026

This study reveals that CSNK1A1 E98 mutations in del(5q) MDS alter kinase signaling and metabolism, creating a stress-tolerant yet inflexible hematopoietic cell state with distinct clinical features and potential therapeutic vulnerabilities.

Hematology-Oncology news

Unveiling the Role of snoRNA-Derived RNAs in Hematopoiesis and Acute Myeloid Leukemia Prognosis

By MedXY 09/09/2026

This article explores the expression and functional impact of snoRNA-derived RNAs in healthy blood formation and acute myeloid leukemia, highlighting their potential as biomarkers and therapeutic targets.

Gastroenterology General Surgery news

Antifibrinolytic Agents Enhance Liver Regeneration and Reduce Posthepatectomy Liver Failure: Translational Insights from Mice to Humans

By MedXY 09/09/2026

Pharmacological reduction of plasminogen via antifibrinolytic agents accelerates liver regeneration after surgery in mice and decreases posthepatectomy liver failure risk in patients, representing a promising therapeutic approach.

Gastroenterology Hematology-Oncology news

Targeting Retinoic Acid-Driven CD16hiCD177+ Neutrophils in Steroid-Resistant GI-GVHD: A Novel Therapeutic Avenue

By MedXY 09/09/2026

Retinoic acid-driven expansion of CD16hiCD177+ neutrophils mediates steroid-resistant gastrointestinal graft-versus-host disease (GI-GVHD). Inhibition of the retinoic acid receptor restores steroid sensitivity and improves outcomes in murine models, suggesting a new treatment strategy.

news Respiratory

Expiratory Pressure Alleviation in CPAP Therapy: Impact on Upper Airway Patency and Obstructive Sleep Apnea Control

By MedXY 09/09/2026

Expiratory pressure alleviation during CPAP treatment reduces upper airway patency, increases residual apnea severity, and necessitates higher therapeutic pressure in severe OSA patients, without affecting treatment adherence.

news Respiratory

Optimizing Patient Expectations and Outcomes: Understanding Days Alive and Out of Hospital After Lung Transplantation

By MedXY 09/09/2026

This study evaluates days alive and out of hospital (DAOH) around lung transplantation, identifying predictors of reduced DAOH in the first post-transplant year and providing insights for tailored patient counseling and care strategies.

news Respiratory

Defining and Achieving Disease Stability in COPD: Insights from Phase 3 Trials

By MedXY 09/09/2026

This article explores disease stability as a key treatment target in COPD, analyzing major phase 3 trials that show stability predicts reduced exacerbations and mortality, supporting its use to guide therapy.

news Respiratory

Reevaluating the Frequent Exacerbator Phenotype in Bronchiectasis: Insights from the EMBARC Registry

By MedXY 09/09/2026

Analysis of over 19,000 bronchiectasis patients across 30 countries reveals a graded risk increase for future exacerbations with each prior event, challenging the fixed threshold concept of frequent exacerbators and confirming consistency across etiologies and regions.

Clinical Updates news Ophthalmology

Cumulative Atopic Disease Burden and Keratoconus: Insights from Large-Scale Cross-Sectional and Longitudinal Analyses

By MedXY 09/09/2026

This review synthesizes evidence linking cumulative atopic diseases—including asthma, atopic dermatitis, and allergic rhinitis—to keratoconus risk, highlighting a dose-dependent association and the role of healthcare utilization in case ascertainment.

Diabetes & Endocrinology news Ophthalmology

Sex-Specific Associations Between Adiposity and Dry Eye Disease: Insights from a Large UK Biobank Study

By MedXY 09/09/2026

Central obesity in women and high overall body fat in men are linked to increased odds of dry eye disease, with distinct metabolic pathways implicated, based on a retrospective analysis of over 480,000 UK Biobank participants.

Clinical Updates news Ophthalmology

Event-Based Progression Detection in Glaucoma: Integrating OCT, OCT Angiography, and Visual Field Metrics

By MedXY 09/09/2026

This review synthesizes recent evidence on event-based progression detection in glaucoma, highlighting that OCTA vessel density may identify progression earlier than structural OCT or visual field testing, with important implications for clinical monitoring and risk stratification.